High Tide Inc. (HITI) 股票分析
医疗保健High Tide Inc.
$2.36
$-0.03 (-1.26%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
High Tide Inc. is a specialized entity operating within the healthcare sector, specifically functioning as a pharmaceutical retailer that focuses on the cannabis retail business across Canada, the United States, and international markets. The company's operational scope encompasses three distinct segments: Bricks and Mortar, E-commerce, and Medical Cannabis Distribution, alongside the manufacturing and distribution of consumption accessories, cannabis, and hemp-derived products. This diverse operational model positions the firm within a regulated and evolving industry that serves both recreational and medical consumer needs. In terms of scale, the company holds a market capitalization of $200.41M and generates annual revenue of $629.85M, supported by an employee base of 1832 individuals. These financial metrics suggest a mid-cap enterprise that has achieved significant revenue generation, yet the relatively modest market cap relative to its revenue base indicates a market that may be pricing in specific risks or future growth trajectories inherent to the cannabis industry.
财务健康
The financial performance of High Tide Inc. for the trailing twelve months reveals a revenue of $629.85M alongside a net income of -$46.734M, resulting in an EBITDA of $29.05M. The substantial gap between the high revenue figure and the significant net loss highlights a challenging cost structure where operating expenses likely exceed gross profits, preventing the conversion of sales into immediate bottom-line earnings. However, the company maintains a positive EBITDA, which serves as a crucial indicator of operational cash generation before interest and taxes. In terms of liquidity and flexibility, the company reports free cash flow of $7.70M, demonstrating the ability to generate cash from operations after capital expenditures, which provides a degree of financial flexibility despite the reported net losses. The margin analysis further elucidates the company's profitability challenges; the gross margin stands at 25.8%, indicating the efficiency of production relative to sales, while the operating margin is a tight 2.3% and the profit margin is negative at -7.4%. These margin levels collectively indicate that while the company can sell its products with moderate gross efficiency, high operating costs are eroding overall profitability. Regarding the balance sheet, the company holds cash of $37.35M against total debt of $112.50M, resulting in a debt-to-equity ratio of 110.31, which characterizes a highly leveraged financial position where debt obligations significantly outweigh equity. The current ratio of 1.43 suggests that the company possesses sufficient current assets to cover its short-term liabilities, indicating an acceptable level of short-term liquidity. Finally, the return metrics show a return on equity of -39.7% and a return on assets of 3.9%, revealing that management has not yet been effective in generating positive returns for shareholders, and the negative ROE reflects the impact of accumulated losses and high leverage on equity value.
估值评估
Valuation metrics for High Tide Inc. present a complex picture, particularly given the company's current profitability status. The trailing P/E ratio is listed as N/A due to the negative net income, whereas the forward P/E is 16.11, implying that the market is pricing in an expected earnings turnaround or positive earnings trajectory in the future. The price-to-book ratio is 3.16, indicating that the market values the company at a significant premium over its book value, which may reflect intangible assets or growth expectations rather than current asset value. Alternative valuation metrics such as the price-to-sales ratio of 0.32 and the EV/EBITDA of 9.95 offer different perspectives; the low P/S ratio suggests the stock trades at a discount relative to its sales volume, while the sub-10 EV/EBITDA multiple indicates a potentially undervalued asset from an enterprise value perspective relative to its earnings power. The stock price has fluctuated within a 52-week range, reaching a high of $4.05 and a low of $1.66. While the specific current price is not provided in the source data, the range defines the volatility floor and ceiling for investors tracking the asset. The beta value is 1.02, which indicates that the stock's price volatility is slightly higher than the broader market, suggesting that the stock will tend to move in tandem with the market but with marginally increased sensitivity to market swings.
Growth & Income
High Tide Inc. demonstrates a robust revenue growth rate of 25.2% year-over-year, signaling strong top-line expansion in the cannabis retail sector. Conversely, the earnings growth rate is N/A due to the current net loss, which implies that while sales are accelerating, profitability has not yet scaled at the same pace, a common characteristic in capital-intensive growth phases. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%. This non-dividend policy indicates that the company chooses to reinvest its earnings and free cash flow entirely into business growth, expansion of retail locations, or debt reduction rather than distributing income to shareholders. Consequently, the overall growth and income profile of High Tide Inc. is characterized by aggressive top-line expansion funded by internal cash flow and external financing, with no current reliance on dividend income for investors.
同行比较
High Tide Inc. (HITI) 在药品零售商行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| High Tide Inc. | HITI | $207.44M | N/A |
| TelyRx Holdings Inc. | TELY.TO | $136.78M | N/A |
| PetMed Express, Inc. | PETS | $45.37M | N/A |
| Pomdoctor Limited | POM | $16.48M | N/A |
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关药品零售商股票
TelyRx Holdings Inc.
$136.78M
PETSPetMed Express, Inc.
$45.37M
POMPomdoctor Limited
$16.48M
SCNXScienture Holdings, Inc.
$16.25M
WGRXWellgistics Health, Inc.
$9.60M
RDGTRidgetech, Inc.
$1.29M
医疗保健热门股票
Eli Lilly and Company
$949.47B
JNJJohnson & Johnson
$554.09B
ABBVAbbVie Inc.
$376.54B
UNHUnitedHealth Group Incorporated
$342.24B
MRKMerck & Co., Inc.
$302.33B
关于High Tide Inc.
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Bricks and Mortar, E-commerce, and Medical Cannabis Distribution segments. It manufactures and distributes consumption accessories; cannabis; and hemp derived products. The company also engages in data analytics; advertising; product sourcing and imports; event-based cannabis retail; medical cannabis distribution; accessories retail; and other related services. It provides its products under the Daily High Club, DankStop, FAB CBD, GC, Nuleaf Naturals, Smoke Cartel, Blessed CBD, Fastendr, Famous Brandz, Queen of Bud, Canna Cabana, Grasscity, Daily High Club, and Valiant Distribution brands. The company sells its products through a network of retail stores, e-commerce platforms, and the wholesale distribution arm. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. The company was founded in 2009 and is headquartered in Calgary, Canada.
公司简介以英文显示。
访问官网 →